Results 11 to 20 of about 3,912,306 (341)
Histopathologic Features of Maculopapular Drug Eruption
Dermatopathology, 2022 Background: Cutaneous adverse drug reaction (CADR) is common in both inpatient and outpatient clinical settings and has been associated with a large variety of medications.
Madison Ernst, Alessio Giubellino
doaj +2 more sources
A Review of Fixed Drug Eruption with a Special Focus on Generalized Bullous Fixed Drug Eruption
Medicina, 2021 Fixed drug eruption (FDE) is a cutaneous adverse drug reaction characterized by the onset of rash at a fixed location on the body each time a specific medication is ingested. With each recurrence, the eruption can involve additional sites.
Hannah J. Anderson, Jason B. Lee
doaj +2 more sources
Fenofibrate-Induced Lichenoid Drug Eruption: A Rare Culprit
Case Reports in Dermatology, 2017 A lichenoid drug eruption is a rare side effect which can occur following the administration of several different medications. Here we describe a unique case of fenofibrate as the causative agent of a lichenoid drug eruption.
Fayeza Mohammed +4 more
doaj +2 more sources
Dermatology Research and Practice, 2015 Background. Generalized fixed drug eruption is a specific variant of fixed drug eruption with multifocal lesions. Diagnosis of this drug reaction is straightforward, but occasionally recognition of the causative drug is not possible. This study was aimed
Hossein Kavoussi +6 more
doaj +2 more sources
Unique skin manifestations of COVID-19: Is drug eruption specific to COVID-19? [PDF]
Journal of dermatological science (Amsterdam), 2020 Takashi SAKAIDA +4 more
openalex +2 more sources
Tenofovir induced lichenoid drug eruption
Avicenna Journal of Medicine, 2015 Cutaneous adverse reactions are a common complication of anti-retroviral therapy. Tenofovir is a newer anti-retroviral drug belonging to the nucleotide reverse transcriptase inhibitor group.
Mrinal Gupta, Heena Gupta, Anish Gupta
doaj +2 more sources
Grover’s-like drug eruption in a patient with metastatic melanoma under ipilimumab therapy [PDF]
Journal of Immunotherapy for Cancer, 2016 BackgroundDermatologic toxicity is an important adverse effect of immune checkpoint inhibitors targeting cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and programmed cell death 1 receptor (PD-1) or PD ligand 1 (PD-L1).
Viktor H. Koelzer +8 more
openalex +2 more sources
Fixed drug eruption by etoricoxib confirmed by patch test [PDF]
Anais Brasileiros de Dermatologia, 2016 Non-steroidal, anti-inflammatory drugs, followed by antibiotics, are the main causes of fixed drug eruption. They provoke one or several round erythematous or bullous lesions that recur in the same place after taking the causative medication.
Aline Soares de Sousa +5 more
openalex +2 more sources
Current Perspectives on Severe Drug Eruption
Clinical reviews in allergy and immunology, 2021 Adverse drug reactions involving the skin are commonly known as drug eruptions. Severe drug eruption may cause severe cutaneous adverse drug reactions (SCARs), which are considered to be fatal and life-threatening, including Stevens-Johnson syndrome (SJS)
Jingzhan Zhang +4 more
semanticscholar +1 more source
High S100A2 expression in keratinocytes in patients with drug eruption
Scientific Reports, 2021 Telaprevir used as a protease inhibitor against hepatitis C virus is frequently associated with cutaneous adverse reactions. To explore a histological biomarker of cutaneous adverse events induced by telaprevir, we systematically searched for genes that ...
M. Yoshioka +8 more
semanticscholar +1 more source